Mandibular Advancement Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Mandibular Advancement Devices Market Trends and Insights

Rising Prevalence and Diagnosis of Obstructive Sleep Apnea

OSA remains underdiagnosed in many health systems, even as screening and access to sleep testing improve. Home sleep testing can reduce the distance between suspected symptoms and a formal diagnosis. The American Academy of Sleep Medicine and the American Academy of Dental Sleep Medicine recommend oral appliance therapy for adults with OSA who cannot tolerate CPAP or prefer an alternative treatment. That clinical position provides a defined referral route for the mandibular advancement devices market. A 2026 longitudinal study reported objective mean oral appliance use of 7.05 hours on nights worn during the first 3 months^{[1]C. M. Shapiro et al., “Objective and Subjective Adherence to Oral Appliance Therapy in Adults With Obstructive Sleep Apnea,” Journal of Clinical Sleep Medicine, link.springer.com.}. Greater awareness of snoring as a possible sign of sleep-disordered breathing can also bring people without an OSA diagnosis into dental sleep practices.

Preference for Noninvasive Alternatives to CPAP

CPAP intolerance continues to support the use of oral appliance therapy among eligible patients. The choice is also becoming more relevant for newly diagnosed people who want care that fits home testing and telehealth-enabled pathways. A 2025 pilot randomized trial found that a digitally fabricated MAD delivered a statistically equivalent reduction in apnea-hypopnea index, or AHI, to a traditional monoblock device. The same study found that lower anterior dental pain was significantly reduced with the digital device. A separate 2025 study reported that a precision-custom protocol reduced AHI to below 10 events per hour in 90% of treated patients and achieved a 63% mean AHI improvement from baseline. These findings can support referral relationships that include sleep physicians, pulmonologists, cardiologists, and dentists.

Digitized Customization Through CAD/CAM and 3D Printing

Digital scanning, computer-aided design and manufacturing, or CAD/CAM, and 3D printing are replacing parts of the conventional impression-based workflow. These methods can improve fit and allow laboratories to produce devices without equivalent increases in labor. A 2026 study found that customized, 3D-printed appliances produced clinical results comparable with CPAP for oxygen desaturation and snoring over 1 year^{[2]F. Verborgh et al., “Dental and Masticatory Outcomes of 3D-Printed Mandibular Advancement Appliance Therapy in Obstructive Sleep Apnea,” Seminars in Orthodontics, doi.org.}. The study also found no significant occlusal change or impairment of masticatory performance over that period. The mandibular advancement devices market, therefore, has a pathway to wider clinical acceptance among dentists concerned about long-term treatment effects. Digital production may also shift competition from basic manufacturing capability toward device mechanics and clinical support.

Expansion of Sleep Clinic and Dental Sleep Medicine Networks

Sleep clinics remain important because they diagnose OSA and coordinate physician-led treatment. Dental clinics are expanding their role in titration, follow-up, and long-term appliance management. Professional training programs provide a route for dentists to develop competence in dental sleep medicine. The mandibular advancement devices market benefits when these clinical networks have clear referral and reimbursement processes. Sleep clinics generally require evidence and physician-facing support from suppliers. Dental clinics also need workflow tools, training, and patient-financing support to manage the appliance after diagnosis.

Dental and Temporomandibular Joint Side Effects

Temporomandibular joint discomfort, occlusal changes, and lower anterior tooth pain can limit long-term adherence. A randomized controlled trial followed 65 patients using 2 MAD designs for 12 months. It documented orofacial pain, masticatory muscle tenderness, temporomandibular joint tenderness, and changes in interdental contact. These effects require careful patient selection and regular follow-up by the prescribing clinician. Manufacturers can support prescriber confidence by supplying repositioning tools and by designing appliances that help manage side effects. The mandibular advancement devices market may be constrained where providers lack experience managing these treatment issues.

Uneven Reimbursement and High Custom Device Cost

Coverage for custom appliances differs substantially among payers and countries. Superior HealthPlan introduced a prior authorization requirement for E0486, the procedure code for a custom-fabricated MAD, effective July 1, 2026. The requirement increases documentation and administrative work for practices serving affected members. In Germany, statutory coverage is available for eligible diagnosed OSA patients, but access depends on CPAP intolerance documentation and a physician's prescription through the sleep medicine pathway. Custom devices priced at USD 1,000 to USD 3,000 or more also face competition from sub-USD 100 boil-and-bite products. The difference in cost can increase online traffic without producing similar revenue for clinically fitted devices.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Custom Devices Support Premium Clinical Care

Custom devices held 56.76% of the mandibular advancement devices market share within the product type in 2025. Their position reflects their adjustment capability and their role in physician-referred treatment. Precision-custom therapy reported a 63% mean AHI improvement across patient subgroups in a 2025 study. That evidence supports the use of fitted appliances for patients who need structured clinical care. Semi-custom products provide an intermediate option with more adjustment than bite devices. They can reduce fabrication time and cost, although digital workflows are narrowing the historic price difference with custom products.

Custom devices are forecast to grow at a CAGR of 9.65% through 2031. The mandibular advancement devices industry is moving toward greater use of digital design and additive manufacturing in this category. Bite devices continue to serve over-the-counter, pharmacy, and primary snoring demand. Their simpler form makes them less suited to clinician-led adjustment and ongoing treatment management. Laboratories that use CAD/CAM and 3D printing can challenge specialist brands on production quality. Suppliers are therefore differentiating with adjustment systems, monitoring features, and evidence that supports treatment outcomes.

By Application: OSA Remains the Largest Clinical Use

Obstructive sleep apnea accounted for 45.76% of application revenue in 2025. Its leading position is linked to reimbursement pathways, physician referrals, and established guidance on oral appliance therapy. Mild to moderate OSA is the core setting for many fitted appliances. Patients who cannot tolerate CPAP are also a defined treatment population. The clinical role of the mandibular advancement device market is consequently closely tied to diagnosis, prescribing, and follow-up within sleep medicine.

Primary snoring is forecast to grow at a CAGR of 9.33% through 2031. Digital and direct-to-consumer pathways can make an appliance more accessible before a formal sleep study occurs. The virtual titration model described in the supplied evidence shows how remote care can establish objective improvement for selected mild to moderate OSA patients. Some people seeking treatment for snoring may later receive an OSA diagnosis and enter a higher-acuity care pathway. Temporomandibular joint syndrome and other applications remain smaller, more stable areas that are often served by orofacial pain specialists and orthodontists. A 2026 study also reported reductions in both respiratory events and sleep bruxism episodes during oral appliance therapy. 

By Material Type: Polymers Lead Digital Appliance Production

Plastic and polymer materials held 63.65% of material revenue in 2025. Their position comes from a combination of biocompatibility and suitability for digital fabrication. Medical-grade polyamide type 12 nylon is used in the Hushd Pro Z-Link, which received FDA clearance in 2025. Polymer trays can be designed for fit, strength, and a smooth finish. These characteristics make them suitable for custom devices produced through 3D printing. The material choice also fits the broader movement toward digitally manufactured appliances.

Metal components are forecast to grow at a CAGR of 9.76% through 2031. Growth relates to titanium and cobalt-chromium parts used in hinges, adjustment arms, and post mechanisms rather than to full-metal appliances. These components can improve durability and dimensional stability in hybrid devices. Their role increases as devices require more precise mandibular positioning. The mandibular advancement device industry uses polymer frames and metal mechanisms to combine patient comfort with reliable adjustment. This design approach is relevant to appliances that incorporate more complex monitoring or mechanical features.

By End User: Dental Clinics Expand Their Management Role

Sleep clinics retained 59.65% of end-user revenue in 2025. They remain the formal diagnostic entry point for many patients with OSA. Sleep studies and physician sign-off commonly support coverage decisions in North America and Europe. The largest portion of the mandibular advancement devices market size at the end-user level, therefore, remained linked to established sleep care pathways in 2025. Hospitals are a smaller but important setting where respiratory, cardiology, dental, and sleep services can be coordinated. Home care and individual use are more associated with self-purchased and lower-value bite devices.

Dental clinics are forecast to grow at a CAGR of 10.32% through 2031. Dentists can manage fitting, titration, follow-up, and monitoring after a sleep clinician has identified an eligible patient. This role grows as training in dental sleep medicine becomes more widely available. Dental practices respond to practice-building support, digital workflow tools, and patient financing. Sleep clinics need suppliers to provide clinical evidence and support physician engagement. The mandibular advancement devices market is thus served by different channel needs within diagnosis and long-term appliance care.

By Distribution Channel: Online Access Broadens the Patient Funnel

Hospitals and dental clinics accounted for 63.65% of distribution revenue in 2025. Clinical channels retain a central role because prescription-required custom devices need professional assessment and follow-up. Retail pharmacies largely serve over-the-counter anti-snoring and bite-device demand. This channel mix separates the service requirements for clinical therapy from those for self-directed purchases. The mandibular advancement devices market size in clinical channels remains supported by the higher value of fitted appliances. Providers can also coordinate titration and address dental side effects that may not be managed in retail settings.

Online stores and pharmacies are forecast to grow at a CAGR of 10.54% through 2031. Growth is supported by consumer use of sleep-health applications and familiarity with remote care. Direct-to-consumer suppliers provide impression-based custom devices through digital ordering paths. Lower online prices can set expectations for convenience and affordability among people who later need more complex treatment. A hybrid channel model can allow digital routes to address lower-acuity snoring demand. Clinical routes are likely to remain important for medium- and high-complexity OSA cases that require diagnosis and supervised care.

Geography Analysis

North America held 43.21% of the global mandibular advancement devices market share in 2025. The United States supports demand through sleep-dental referral networks, commercial insurance coverage, and active device regulation. E0486 provides a billing route for custom-fabricated appliances, although new prior authorization policies can increase administrative work for practices. Canada has variable provincial coverage, while Mexico relies more on private-pay dental demand. The region has competition across specialist device suppliers, laboratory groups, and direct-to-consumer channels.

Europe is the second-largest regional area for these appliances. Germany is a key market because its coverage and clinical guidance support the use of individually fitted devices for eligible people with OSA. The DGSM 2025 S3 guideline positioned individually fitted MADs alongside CPAP as a first-line therapy for mild OSA, defined as AHI 5 to 15. The guideline cited a meta-analysis of 14 randomized controlled trials involving 2,100 participants. It also reported long-term oral appliance compliance of 75% to 85%, compared with 30% to 50% for CPAP users at 6 months^{[3]Deutsche Gesellschaft für Schlafforschung und Schlafmedizin, “Nicht Erholsamer Schlaf / Schlafstörungen,” Deutsche Gesellschaft für Schlafforschung und Schlafmedizin, dgsm.de.}. The United Kingdom, Spain, France, and Italy offer additional demand through guided care pathways, dental sleep clinics, specialist availability, and private payer coverage.

Asia-Pacific is forecast to expand at a CAGR of 8.54% through 2031. China, Japan, South Korea, India, and Australia are increasing diagnoses and developing dental sleep medicine capacity. Japan’s aging population, South Korea’s dental technology investment, and Australia’s private dental sector favor premium custom appliances. India and Southeast Asia have earlier-stage reimbursement and fewer specialists, which limits near-term access. Their unmet need and expanding private sleep care create scope for future adoption. The Middle East and Africa, along with South America, remain smaller regions where private sleep clinics and awareness of oral appliance therapy are growing.